April 1st 2025
William Wainwright, business development manager at Iwata Label USA, discusses the practical security benefits of functional labels at INTERPHEX 2025.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Key parameters to be optimized in the development and manufacturing of oral solid-dosage forms
April 2nd 2017Anil Kane, executive director, Global Head of Formulation Sciences, Pharmaceutical Development Services at Patheon discusses key parameters in the development and manufacturing of oral solid-dosage forms.
Continuous Manufacturing: Separating Hype from Reality
April 1st 2017Continuous manufacturing will not work for all pharmaceuticals, but the right infrastructure, senior management support, and planning from the earliest stages of drug development could eventually allow up to 80-90% of small-molecule APIs to be made continuously, says Paul Sharratt, head of process science and modeling at Singapore’s Institute of Chemical and Engineering Sciences.
Gluing Pills Technology for the Production of Multi-Layer Tablets
April 1st 2017This novel technology was developed in response to challenges involved in conventional manufacturing of multilayer tablets, including in-line control of the tablet weight, the tendency to delamination, direct contact between the two tablet layers, and cross contamination.
How to Avoid the Number One Reason for Receiving FDA 483s
March 15th 2017An enterprise quality management software system can minimize human error and help pharmaceutical manufacturers maintain standard operating procedures to prevent deviations from GMP resulting from not having or following written procedures.